Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • Topics
  • Health Policy
  • Benign Conditions
  • Videos
  • Bladder Cancer
  • Residents Lounge
  • Prostate Cancer
  • Job Board
MJH Life Sciences

SUBSCRIBE: Print / Digital / eNewsletter

AUA annual meeting
AUA annual meeting

AUA Annual Meeting

John L. Gore, MD

UTUC agent linked to high rate of disease eradication

May 5, 2019
  • John Schieszer

“UGN-101… has the potential to change practice for patients with low-grade renal pelvis cancer,” says researcher John L. Gore, MD.

  • READ >>
Image courtesy of Valencia Technologies Corp.

OAB device produces durable efficacy at 12 months

May 5, 2019
  • John Schieszer

Researchers found that 30 of 46 study participants (65%) experienced more than a 50% improvement in urgency urinary incontinence with the nickel-sized device.

  • READ >>
monsitj - stock.adobe.com

Laser lithotripsy: Is there a saturation point for frequency?

May 4, 2019
  • Cheryl Guttman Krader

Increasing the frequency setting on a holmium:YAG laser increases stone fragmentation, but determining the saturation point at which efficiency plateaus requires further study.

  • READ >>
Darwin Brandis – stock.adobe.com

Post-procedure opioid Rx may be unnecessary

May 4, 2019
  • Cheryl Guttman Krader

The majority of medication prescribed to patients undergoing outpatient urologic procedures goes unused, prospective data reveal.

  • READ >>
maxsim - stock.adobe.com

What drives costs of prostate cancer care?

May 3, 2019
  • Cheryl Guttman Krader

An analysis of Medicare expenditures in the first year after a diagnosis of prostate cancer shows that 5% of patients account for almost 25% of the total spending.

  • READ >>
Kateryna_Kon - stock.adobe.com

Enzalutamide vs. abiraterone: Survival, care costs compared

May 3, 2019
  • Cheryl Guttman Krader

The use of enzalutamide (XTANDI) and abiraterone acetate (ZYTIGA) show differences in overall survival and health care costs when used to treat chemotherapy-naïve metastatic castrate-resistant prostate cancer.

  • READ >>
Victor Nitti, MD

Dr. Nitti: 32 new courses on tap at AUA 2019

May 1, 2019
  • Barry Kogan, MD

With the AUA annual meeting quickly approaching, Victor W. Nitti, MD, chair of the AUA Office of Education, provides a snapshot of new course offerings and other AUA educational opportunities.

  • READ >>
abricotine - stock.adobe.com

AUA 2019: Experts outline the must-see presentations in Chicago

April 19, 2019
  • Richard R. Kerr

In advance of this year’s AUA annual meeting, Urology Times asked members of our editorial board to choose the top presentations in their subspecialty.

  • READ >>
WavebreakmediaMicro - stock.adobe.com

Can nurse practitioners see Medicare patients on their own?

March 27, 2019
  • Ray Painter, MD
  • Mark Painter

Ray Painter, MD, and Mark Painter also answer coding questions regarding vasectomy and code 50543.

  • READ >>

Waterjet fares better vs. TURP in large prostates

September 27, 2018
  • Laird Harrison

Men with large prostates experience more relief from BPH with treatment by Aquablation therapy (using the AquaBeam System) than with transurethral resection of the prostate, researchers say.

  • READ >>

Pages

  • 1
  • 2
  • 3
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Prostate Cancer
  • GU Cancers Symposium
  • AUA Annual Meeting
  • Bladder Cancer
  • Malpractice Consult
Optimizing Treatment Decisions in Metastatic Castration-Resistant Prostate Cancer
Filling the gap in BPH care
Nocturia: A Nighttime Condition With Daytime Consequences

Current Issue

Vol 47 No 11
Nov 13, 2019 Vol 47 No 11
Digital Edition
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".